A Sitewise Model of Natural Selection on Individual Antibodies via a Transformer-Encoder. [PDF]
Matsen FA +9 more
europepmc +1 more source
Characterizing Cutaneous α‐Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes
ABSTRACT Objective Cutaneous phosphorylated α‐synuclein (p‐syn) and α‐synuclein seeding activity are promising biomarkers for Parkinson's disease (PD), but their clinical value remains uncertain due to disease heterogeneity. This study evaluates these two biomarkers in PD patients to inform phenotype‐specific diagnosis and disease severity assessment ...
Yuting Jin +8 more
wiley +1 more source
Darwinism: An Exposition of the Theory of Natural Selection With Some of Its Applications [PDF]
Wallace, Alfred Russell
core +1 more source
The Price Equation Reveals a Universal Force-Metric-Bias Law of Algorithmic Learning and Natural Selection. [PDF]
Frank SA.
europepmc +1 more source
Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias +3 more
wiley +1 more source
Natural selection on reproductive timing varies by education in twentieth-century Estonia. [PDF]
Meitern R, Hõrak P.
europepmc +1 more source
ABSTRACT Objective The prognosis of glioblastoma (GBM) remains highly unfavorable, largely due to high tumor heterogeneity and an immunosuppressive microenvironment. However, the functional role of PANoptosis in this context is poorly understood. Methods Patients were stratified via K‐means clustering. A risk score model was constructed using prognosis‐
Langfei Tian +6 more
wiley +1 more source
Natural Selection of a Virus-Protective FUT2 Variant Following the Transition to Agriculture. [PDF]
Nordgren J +8 more
europepmc +1 more source
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto +12 more
wiley +1 more source
The <i>MUC19</i> gene: An evolutionary history of recurrent introgression and natural selection. [PDF]
Villanea FA +13 more
europepmc +1 more source

